Skip to main content

General AI News

AI Life Science Firm Metis TechBio Set for HK Debut After IPO

Source: Bloomberg
AI Life Science Firm Metis TechBio Set for HK Debut After IPO

Metis TechBio, an AI-driven biotechnology company focused on drug delivery and formulation, surged as much as 185% on its Hong Kong Stock Exchange debut Wednesday. The strong first-day performance adds to a recent trend of significant gains for newly listed companies in Hong Kong.

Read Full Article at Bloomberg

Related Articles